| Established track record of operations along with experienced management
MAS Additives Private Limited (MAPL), incorporated in 2008 in Mumbai by Mr. Manish Shah and family, is engaged in trading various chemicals, primarily polymer additives used in PVC films, plastic pipes, and other plastic products. The promoters possess over two decades of experience in the trading business. The extensive experience of the promoters has helped the group to established strong ties with its suppliers and customers. The company is an authorized distributor for companies such as Mitsui Chemicals India Private Limited and Kaneka Corporation amongst others.
Acuité believes the company shall continue to benefit from its experienced management and established relationships with customers and suppliers.
Improving scale of operations:
The company’s revenue increased by ~18%, reaching to Rs. 133.77 Cr. as of March 31, 2025, compared to Rs. 113.02 Cr. in the previous year. The improvement in the revenue is primarily driven by improvement in price realisation. The operating profit margin of the company stood at 5.52% in FY2025 against 1.81% in FY2024. The improvement in operating profit margin is due to improvement in price realization and marginal decline in operating expenses. Further, the PAT margin stood at 5.44 percent in FY2025 against 3.26 percent in FY2024.
Acuité believes that going forward, the sustenance of growth in revenues while maintaining its profitability margins will remain a key rating sensitivity.
Healthy Financial Risk Profile
The financial risk profile of the company is healthy, marked by healthy net worth, debt protection metrics, and below unity gearing. The net worth of the company has improved to Rs. 57.85 Cr. as on March 31st, 2025, against Rs. 50.57 Cr. as on March 31st, 2024, owing to accretion of profit into reserves. The gearing level of company stood below unity at 0.06 times as on March 31, 2025, as compared to 0.03 times as on March 31, 2024. The Total Outside Liabilities/Tangible Net Worth (TOL/TNW) stood at 0.43 times as on March 31, 2025 as against 0.45 times as on March 31,2024. The debt protection metrices of the company remain healthy marked by Interest Coverage ratio of 30.55 times in FY2025 as against 22.66 times in FY2024 and debt service coverage ratio (DSCR) of 23.57 times for March 31, 2025 as against 18.10 times in FY2024. The net cash accruals to total debt (NCA/TD) stood at 2.39 times as on March 31, 2025 as compared to 3.05 times as on March 31, 2024.
Acuité believes that the financial risk profile will remain healthy in the absence of any major debt funded capital expenditure plan over the medium term.
|
| Moderate Working Capital Management:
The company have moderate working capital cycle as evident by Gross Current Asset (GCA) Days of 98 days as on March 31, 2025 as against 126 days as on March 31, 2024. The GCA days improved on account of decline in debtor days. The debtor days stood at 49 days in FY2025 as against 69 days in FY2024. The company offers a credit period ranging from 45 to 60 days. The inventory days stood at 26 days in FY2025 as compared to 25 days in FY2024. Further, the creditor days stood at 52 days in FY2025 as compared to 66 days in FY2024. The average utilization of the fund based working capital limits of the company remained at 24% in last seven months ended Oct 2025.
Going ahead, the working capital operations of the company are expected to remain at the similar levels over the medium term.
Highly competitive and fragmented industry
Provided the commodity nature of the Chemical that the company deals in, the industry is highly competitive and fragmented with several small to mid-size players in the market. The company faces intensive competition from peers and international players. This limits the bargaining power of the company and limits its profitability. Furthermore, the profitability of the company is susceptible to fluctuations in chemical pricing.
|